Effectiveness of fluticasone propionate in patients with moderate asthma: a dose-ranging study
Authors:
- John C. SelnerJSJohn C. Selner
- Louis M. MendelsonLMLouis M. Mendelson
- Frank HampelFHFrank Hampel
- Amy SchabergASAmy Schaberg
- 1 July 1996
- journal article
- clinical trial
- Published by Elsevier in Clinical Therapeutics
- Vol. 18 (4) , 635-646
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- A 12-Week Dose-Ranging Study of Fluticasone Propionate Powder in the Treatment of AsthmaJournal of Asthma, 1996
- Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthmaJournal of Allergy and Clinical Immunology, 1994
- A comparison of fluticasone propionate 200 μg/day with beclomethasone dipropionate 400 μg/day in adult asthmaAllergy, 1994
- Evaluation of fluticasone propionate (500 μg day−1) administered either as dry powder via a Diskhaler® inhaler or pressurized inhaler and compared with beclomethasone dipropionate (1000 μg day−1) administered by pressurized inhalerRespiratory Medicine, 1993
- Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. International Study Group.Thorax, 1993
- AsthmaNew England Journal of Medicine, 1992
- Comparison of oral-steroid sparing by high-dose and low-dose inhaled steroid in maintenance treatment of severe asthmaThe Lancet, 1992
- Inhaled corticosteroids: benefits and risks.Thorax, 1992
- Structure-activity relationships of topically active steroids: the selection of fluticasone propionateRespiratory Medicine, 1990
- AEROSOL BECLOMETHASONE DIPROPIONATE: A DOSE-RESPONSE STUDY IN CHRONIC BRONCHIAL ASTHMAThe Lancet, 1973